Skip to main content
. 2022 Mar 4;306(4):1135–1146. doi: 10.1007/s00404-021-06382-3

Fig. 1.

Fig. 1

Flowchart of our retrospective study design. AEH atypical endometrial hyperplasia, EEC endometrioid endometrial carcinoma, MM morular metaplasia, BEF MM before treatment group, SUS sustained MM group, DUR MM during treatment group